Adisetiyo, V., & Gray, K. M. (2017). Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder-A systematic review. The American Journal on Addictions, 26(2), 99–111. https://doi.org/10.1111/ajad.12500

Article  PubMed  Google Scholar 

Boland, H., DiSalvo, M., Fried, R., Woodworth, K. Y., Wilens, T., Faraone, S. V., & Biederman, J. (2020). A literature review and meta-analysis on the effects of ADHD medications on functional outcomes. Journal of Psychiatric Research, 123, 21–30. https://doi.org/10.1016/j.jpsychires.2020.01.006

Article  PubMed  Google Scholar 

Chang, Z., Lichtenstein, P., Halldner, L., D’Onofrio, B., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2014). Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry, 55(8), 878–885. https://doi.org/10.1111/jcpp.12164

Article  PubMed  Google Scholar 

Choi, Y., Shin, J., Cho, K. H., & Park, E.-C. (2017). Change in household income and risk for attention deficit hyperactivity disorder during childhood: A nationwide population-based cohort study. Journal of Epidemiology, 27(2), 56–62. https://doi.org/10.1016/j.je.2016.09.004

Article  PubMed  Google Scholar 

Crunelle, C. L., van den Brink, W., Moggi, F., Konstenius, M., Franck, J., Levin, F. R., van de Glind, G., Demetrovics, Z., Coetzee, C., Luderer, M., Schellekens, A., & Matthys, F. (2018). International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit/hyperactivity disorder. European Addiction Research, 24(1), 43–51. https://doi.org/10.1159/000487767

Article  PubMed  Google Scholar 

Cunill, R., Castells, X., González-Pinto, A., Arrojo, M., Bernardo, M., Sáiz, P. A., Flórez, G., Torrens, M., Tirado-Muñoz, J., Fonseca, F., Arranz, B., Garriga, M., Goikolea, J. M., Zorrilla, I., Becoña, E., López, A., & San, L. (2021). Guía de práctica clínica para el tratamiento farmacológico y psicológico de los pacientes adultos con trastorno por déficit de atención con hiperactividad y un diagnóstico comórbido de trastorno por uso de sustancias. Adicciones, 34(2), 168. https://doi.org/10.20882/adicciones.1569

Article  Google Scholar 

Dalsgaard, S., Mortensen, P. B., Frydenberg, M., & Thomsen, P. H. (2014). ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - A naturalistic long-term follow-up study. Addictive Behaviors, 39(1), 325–328. https://doi.org/10.1016/j.addbeh.2013.09.002

Article  PubMed  Google Scholar 

Danielson, M. L., Bitsko, R. H., Ghandour, R. M., Holbrook, J. R., Kogan, M. D., & Blumberg, S. J. (2018). Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016. Journal of Clinical Child & Adolescent Psychology, 47(2), 199–212. https://doi.org/10.1080/15374416.2017.1417860

Article  Google Scholar 

Doshi, J. A., Hodgkins, P., Kahle, J., Sikirica, V., Cangelosi, M. J., Setyawan, J., Erder, M. H., & Neumann, P. J. (2012). Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States. Journal of the American Academy of Child & Adolescent Psychiatry, 51(10), 990-1002.e2. https://doi.org/10.1016/j.jaac.2012.07.008

Article  Google Scholar 

Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., Rohde, L. A., Yang, L., Cortese, S., Almagor, D., Stein, M. A., Albatti, T. H., Aljoudi, H. F., Alqahtani, M. M. J., Asherson, P., & Wang, Y. (2021). The World Federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022

Article  Google Scholar 

George, A. J. (2000). Central nervous system stimulants. Best Practice & Research Clinical Endocrinology & Metabolism, 14(1), 79–88. https://doi.org/10.1053/beem.2000.0055

Article  CAS  Google Scholar 

Ginsberg, Y., Quintero, J., Anand, E., Casillas, M., & Upadhyaya, H. P. (2014). Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: A review of the literature. The Primary Care Companion for CNS Disorders, 16(3). https://doi.org/10.4088/PCC.13r01600

Halmøy, A., Fasmer, O. B., Gillberg, C., & Haavik, J. (2009). Occupational outcome in adult ADHD: Impact of symptom profile, comorbid psychiatric problems, and treatment. Journal of Attention Disorders, 13(2), 175–187. https://doi.org/10.1177/1087054708329777

Article  PubMed  Google Scholar 

Humphreys, K. L., Eng, T., & Lee, S. S. (2013). Stimulant medication and substance use outcomes: A meta-analysis. JAMA Psychiatry, 70(7), 740–749. https://doi.org/10.1001/jamapsychiatry.2013.1273

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huss, M., Poustka, F., Lehmkuhl, G., & Lehmkuhl, U. (2008). No increase in long-term risk for nicotine use disorders after treatment with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD): Evidence from a non-randomised retrospective study. Journal of Neural Transmission, 115(2), 335–339. https://doi.org/10.1007/s00702-008-0872-3

Article  CAS  PubMed  Google Scholar 

Jain, S., Jain, R., & Islam, J. (2011). Do stimulants for ADHD increase the risk of substance use disorders? Current Psychiatry, 10, 20–24.

Google Scholar 

Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., Spencer, T., Ustun, T. B., Walters, E. E., & Zaslavsky, A. M. (2006). The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. American Journal of Psychiatry, 163(4), 716–723. https://doi.org/10.1176/ajp.2006.163.4.716

Article  PubMed  Google Scholar 

Lakhan, S. E., & Kirchgessner, A. (2012). Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: Misuse, cognitive impact, and adverse effects. Brain and Behavior, 2(5), 661–677. https://doi.org/10.1002/brb3.78

Article  PubMed  PubMed Central  Google Scholar 

Lambert, N. (2005). The contribution of childhood ADHD, conduct problems, and stimulant treatment to adolescent and adult tobacco and psychoactive substance abuse. Ethical Human Psychology and Psychiatry, 7(3), 197–221. https://doi.org/10.1891/1559-4343.7.3.197

Article  Google Scholar 

Mariani, J. J., & Levin, F. R. (2007). Treatment strategies for co-occurring ADHD and substance use disorders. The American Journal on Addictions, 16(s1), 45–56. https://doi.org/10.1080/10550490601082783

Article  PubMed  PubMed Central  Google Scholar 

Molife, C., Haynes, V. S., Nyhuis, A., Faries, D. E., Gelwicks, S., Kelsey, D. K., & Alatorre, C. I. (2018). Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine. Current Medical Research and Opinion, 34(4), 619–632. https://doi.org/10.1080/03007995.2017.1421918

Article  PubMed  Google Scholar 

Ohnishi, T., Kobayashi, H., Yajima, T., Koyama, T., & Noguchi, K. (2019). Psychiatric comorbidities in adult attention-deficit/hyperactivity disorder: Prevalence and patterns in the routine clinical setting. Innovations in Clinical Neuroscience, 16(9–10), 11–16.

PubMed  PubMed Central  Google Scholar 

Parish, W., & Mark, T. L. (2022). The cost of adding substance use disorder services and professionals to Medicare. LegalActionCenter. https://www.lac.org/assets/files/LAC_Medicare_Budget_Impact_Report_08_08_2022-submitted.pdf

Perugi, G., Pallucchini, A., Rizzato, S., De Rossi, P., Sani, G., Maremmani, A. G., Pinzone, V., & Maremmani, I. (2019). Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD). Expert Opinion on Pharmacotherapy, 20(3), 343–355. https://doi.org/10.1080/14656566.2018.1551878

Article  CAS  PubMed  Google Scholar 

Peterson, C., Li, M., Xu, L., Mikosz, C. A., & Luo, F. (2021). Assessment of annual cost of substance use disorder in US hospitals. JAMA Network Open, 4(3), e210242. https://doi.org/10.1001/jamanetworkopen.2021.0242

Article  PubMed  PubMed Central  Google Scholar 

Posner, J., Kass, E., & Hulvershorn, L. (2014). Using stimulants to treat ADHD-related emotional lability. Current Psychiatry Reports, 16(10), 478. https://doi.org/10.1007/s11920-014-0478-4

Article  PubMed  PubMed Central  Google Scholar 

Quinn, P. D., Chang, Z., Hur, K., Gibbons, R. D., Lahey, B. B., Rickert, M. E., Sjölander, A., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2017). ADHD medication and substance-related problems. American Journal of Psychiatry, 174(9), 877–885. https://doi.org/10.1176/appi.ajp.2017.16060686

Article  PubMed  Google Scholar 

Rivas-Vazquez, R. A., Diaz, S. G., Visser, M. M., & Rivas-Vazquez, A. A. (2023). Adult ADHD: Underdiagnosis of a treatable condition. Journal of Health Service Psychology, 49(1), 11–19. https://doi.org/10.1007/s42843-023-00077-w

Article  PubMed  PubMed Central  Google Scholar 

Schein, J., Adler, L. A., Childress, A., Gagnon-Sanschagrin, P., Davidson, M., Kinkead, F., Cloutier, M., Guérin, A., & Lefebvre, P. (2022). Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective. Journal of Managed Care & Specialty Pharmacy, 28(2), 168–179. https://doi.org/10.18553/jmcp.2021.21290

Article  Google Scholar 

Spalding, W., Farahbakhshian, S., Maculaitis, M. C., Peck, E. Y., & Goren, A. (2022). The association of oral stimulant medication adherence with work productivity among adults with ADHD. Journal of Attention Disorders, 26(6), 831–842. https://doi.org/10.1177/10870547211020113

Article  PubMed  Google Scholar 

Substance Abuse and Mental Health Services Administration. (2021). Key substance use and mental health indicators in the United States: results from the 2020 National Survey on